Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Court rejects Novo bid to block Lilly obesity drug ads

Novo failed to prove that Lilly’s campaign — which featured claims of obesity drug superiority — meaningfully harmed the Danish company’s sales, a federal judge ruled.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at biopharmadive.com →

More in Health & Medicine

More from Tuesday 27 October →